Ptc Therapeutics, Inc. financial data

Symbol
PTCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Warren Corporate Center Drive, Warren, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 210 % +56.2%
Quick Ratio 5.34 % -16.6%
Debt-to-equity -299 % +23%
Return On Assets -24.4 % +43.9%
Operating Margin -14.9 % +81.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.1M shares +2.2%
Common Stock, Shares, Outstanding 77M shares +1.98%
Entity Public Float 2.33B USD +9.44%
Common Stock, Value, Issued 76K USD +1.33%
Weighted Average Number of Shares Outstanding, Basic 76.9M shares +2.05%
Weighted Average Number of Shares Outstanding, Diluted 76.9M shares +2.05%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 901M USD +12.8%
Research and Development Expense 531M USD -27.6%
Operating Income (Loss) -134M USD +79.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -425M USD +41.6%
Income Tax Expense (Benefit) 27.7M USD
Net Income (Loss) Attributable to Parent -453M USD +29.4%
Earnings Per Share, Basic -5.95 USD/shares +31.2%
Earnings Per Share, Diluted -5.95 USD/shares +31.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 526M USD +218%
Marketable Securities, Current 487M USD +276%
Inventory, Net 35.7M USD -0.23%
Assets, Current 1.28B USD +137%
Property, Plant and Equipment, Net 63.2M USD -25.7%
Operating Lease, Right-of-Use Asset 59.5M USD -36.8%
Intangible Assets, Net (Excluding Goodwill) 330M USD -22%
Goodwill 82.3M USD 0%
Assets 1.84B USD +46.2%
Accounts Payable, Current 13.3M USD -30.6%
Employee-related Liabilities, Current 46.2M USD -34.7%
Contract with Customer, Liability, Current 801K USD -40.7%
Liabilities, Current 611M USD +24.1%
Deferred Income Tax Liabilities, Net 55.9M USD +7.67%
Operating Lease, Liability, Noncurrent 82.8M USD -17%
Other Liabilities, Noncurrent 77K USD -45.4%
Liabilities 2.9B USD +50%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.34M USD -145%
Retained Earnings (Accumulated Deficit) -3.58B USD -14.5%
Stockholders' Equity Attributable to Parent -1.05B USD -57.2%
Liabilities and Equity 1.84B USD +46.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 70.8M USD
Net Cash Provided by (Used in) Financing Activities 540K USD -86.8%
Net Cash Provided by (Used in) Investing Activities -115M USD -297%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 77M shares +1.98%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -45.7M USD +26.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 540M USD +198%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.67M USD -71.7%
Deferred Tax Assets, Valuation Allowance 834M USD +24%
Deferred Tax Assets, Gross 841M USD +24.3%
Operating Lease, Liability 96.9M USD -13%
Payments to Acquire Property, Plant, and Equipment 9.59M USD -6.64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -467M USD +30.1%
Lessee, Operating Lease, Liability, to be Paid 190M USD -26.4%
Property, Plant and Equipment, Gross 138M USD +25.8%
Operating Lease, Liability, Current 14.1M USD +20.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.2M USD -20.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 16.2M USD -11.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11.5%
Deferred Income Tax Expense (Benefit) -1K USD +75%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 92.7M USD -36.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 14M USD -30.1%
Unrecognized Tax Benefits 1.36M USD -95%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.9M USD -10.2%
Operating Lease, Payments 3.95M USD +3.6%
Additional Paid in Capital 2.53B USD +3.42%
Amortization of Intangible Assets 135M USD -25.7%
Depreciation, Depletion and Amortization 55.4M USD +29.4%
Deferred Tax Assets, Net of Valuation Allowance 7.48M USD +66.8%
Share-based Payment Arrangement, Expense 73.9M USD -34.3%